mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.7 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |